Literature DB >> 18677142

Once-daily dosing of gentamicin in obstetrics and gynecology.

Kristy Ward1, Regan N Theiler.   

Abstract

Gentamicin, an aminoglycoside with broad antimicrobial activity, is commonly used in both obstetrics and gynecology. Traditional dosing regimens for gentamicin have called for 3 times daily dosing, but recent insights into the pharmacodynamics of the drug have led to multiple studies of once-daily dosing regimens. Many studies have demonstrated efficacy, safety, and economy of the 24-hour dosing interval, resulting in recommendations that this become the standard for aminoglycoside administration. However, because of the unique considerations for drug administration in pregnant and postpartum women, the once-daily dosing regimens have not been widely adopted. Additional studies in pregnant and postpartum women have demonstrated therapeutic noninferiority, no increase in adverse events, and significant cost savings with once-daily dosing versus 3 times daily dosing of gentamicin. We review the literature and present rationale based on multiple controlled studies supporting single-daily dosing of gentamicin, 5 mg/kg/d actual body weight, for many common obstetrics-gynecology infections.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18677142      PMCID: PMC2650501          DOI: 10.1097/GRF.0b013e31818091cd

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN: 0009-9201            Impact factor:   2.190


  15 in total

1.  Treatment of STDs: updated guidelines from the CDC.

Authors:  Cynthia Goetz
Journal:  JAAPA       Date:  2007-07

Review 2.  Antibiotic use in pregnancy and lactation: what is and is not known about teratogenic and toxic risks.

Authors:  Gerard G Nahum; Kathleen Uhl; Dianne L Kennedy
Journal:  Obstet Gynecol       Date:  2006-05       Impact factor: 7.661

3.  High compared with standard gentamicin dosing for chorioamnionitis: a comparison of maternal and fetal serum drug levels.

Authors:  Gregory J Locksmith; Anita Chin; Tammy Vu; Karen E Shattuck; Gary D V Hankins
Journal:  Obstet Gynecol       Date:  2005-03       Impact factor: 7.661

Review 4.  Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

Authors:  W A Craig
Journal:  Clin Infect Dis       Date:  1998-01       Impact factor: 9.079

5.  A randomized, prospective study comparing once-daily gentamicin versus thrice-daily gentamicin in the treatment of puerperal infection.

Authors:  A G Mitra; M K Whitten; S L Laurent; W E Anderson
Journal:  Am J Obstet Gynecol       Date:  1997-10       Impact factor: 8.661

6.  Gentamicin and clindamycin therapy in postpartum endometritis: the efficacy of daily dosing versus dosing every 8 hours.

Authors:  Jeffrey C Livingston; Eloisa Llata; Eliza Rinehart; Colleen Leidwanger; Bill Mabie; Bassam Haddad; Baha Sibai
Journal:  Am J Obstet Gynecol       Date:  2003-01       Impact factor: 8.661

7.  Rapid gentamicin elimination in obstetric patients.

Authors:  D E Zaske; R J Cipolle; R G Strate; J W Malo; M F Koszalka
Journal:  Obstet Gynecol       Date:  1980-11       Impact factor: 7.661

8.  Gentamicin dosing in postpartum women with endometritis.

Authors:  G G Briggs; P Ambrose; M P Nageotte
Journal:  Am J Obstet Gynecol       Date:  1989-02       Impact factor: 8.661

9.  Comparison of CT- or ultrasound-guided drainage with concomitant intravenous antibiotics vs. intravenous antibiotics alone in the management of tubo-ovarian abscesses.

Authors:  N Goharkhay; U Verma; F Maggiorotto
Journal:  Ultrasound Obstet Gynecol       Date:  2007-01       Impact factor: 7.299

10.  The pharmacokinetics of once-daily dosing with gentamicin in women with postpartum endometritis.

Authors:  J A Sunyecz; H C Wiesenfeld; R P Heine
Journal:  Infect Dis Obstet Gynecol       Date:  1998
View more
  7 in total

Review 1.  Challenges in interventional radiology: the pregnant patient.

Authors:  Eunice K Moon; Weiping Wang; James S Newman; Maria Del Pilar Bayona-Molano
Journal:  Semin Intervent Radiol       Date:  2013-12       Impact factor: 1.513

2.  Megalin-targeting liposomes for placental drug delivery.

Authors:  Ali A Alfaifi; Rodrigo S Heyder; Elizabeth R Bielski; Rashed M Almuqbil; Mahendra Kavdia; Phillip M Gerk; Sandro R P da Rocha
Journal:  J Control Release       Date:  2020-05-24       Impact factor: 9.776

Review 3.  Antibiotics for meconium-stained amniotic fluid in labour for preventing maternal and neonatal infections.

Authors:  Thitiporn Siriwachirachai; Ussanee S Sangkomkamhang; Pisake Lumbiganon; Malinee Laopaiboon
Journal:  Cochrane Database Syst Rev       Date:  2014-11-06

4.  Once versus individualized multiple daily dosing of aminoglycosides in critically ill patients.

Authors:  A Abdel-Bari; M Sherif Mokhtar; Nagwa Ali Sabry; Sanaa Abd El-Shafi; Naglaa Samir Bazan
Journal:  Saudi Pharm J       Date:  2010-11-04       Impact factor: 4.330

5.  Predictive performance of gentamicin dosing nomograms.

Authors:  Jieon Lee; Seonghae Yoon; Donghoon Shin; HyeKyung Han; Hyungmi An; Jongtae Lee; Kyoung Soo Lim; Kyung-Sang Yu; Howard Lee
Journal:  Drug Des Devel Ther       Date:  2014-08-16       Impact factor: 4.162

6.  Top 10 Pearls for the Recognition, Evaluation, and Management of Maternal Sepsis.

Authors:  Andrea Shields; Viviana de Assis; Torre Halscott
Journal:  Obstet Gynecol       Date:  2021-08-01       Impact factor: 7.661

7.  Gentamicin-mediated ototoxicity and nephrotoxicity: A clinical trial study.

Authors:  Parviz Saleh; Shamsi Abbasalizadeh; Saman Rezaeian; Mohammad Naghavi-Behzad; Reza Piri; Hojjat Hossein Pourfeizi
Journal:  Niger Med J       Date:  2016 Nov-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.